General Hospital Psychiatry
Volume 30, Issue 1 , Pages 40-48, January 2008

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis☆

  • Dawn M. Ehde, Ph.D.

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    • Corresponding Author InformationCorresponding author. Department of Rehabilitation Medicine, Seattle, WA 98104-2499, USA. Tel.: +1 206 731 2811; fax: +1 206 731 8580.
    • ,
  • George H. Kraft, M.D.

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    • Department of Neurology, University of Washington School of Medicine, Seattle, WA 98195, USA
    • ,
  • Lydia Chwastiak, M.D., M.P.H.

      Affiliations

    • Department of Psychiatry, Yale School of Medicine, New Haven, CT 06519, USA
    • ,
  • Mark D. Sullivan, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA
    • ,
  • Laura E. Gibbons, Ph.D.

      Affiliations

    • Department of Psychosocial and Community Health, University of Washington School of Nursing, Seattle, WA 98195, USA
    • ,
  • Charles H. Bombardier, Ph.D.

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    • ,
  • Rohini Wadhwani, B.A.

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA

Received 19 June 2007; accepted 8 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Disclosure: GlaxoSmithKline provided the study medications (placebo and active) but did not participate in study conceptualization, study design, data analyses or manuscript preparation.

PII: S0163-8343(07)00142-9

doi:10.1016/j.genhosppsych.2007.08.002

General Hospital Psychiatry
Volume 30, Issue 1 , Pages 40-48, January 2008

Article Tools

* Image Usage & Resolution